Centrus Energy

Does the core business genuinely avoid or reduce emissions, or build climate resilience? Share of revenue that is actually 'green'. Fossil-dependent models score low.

Centrus is the sole US producer of HALEU, unlocking a critical fuel supply bottleneck for next-generation advanced reactors that generate carbon-free electricity — a genuine enabler role — but Centrus itself enriches uranium rather than generating zero-carbon power, so its direct emissions avoidance is indirect and contingent on downstream reactor deployment.

Credible, science-based targets (SBTi), a real net-zero plan with progress to date, and CDP disclosure — not just a dated press release.

No SBTi-validated targets, no CDP submission, and no net-zero pledge were found in any public filing or on the company website; SEC filings reference carbon-free nuclear power as a mission framing but contain zero quantified GHG reduction commitments or timelines for Centrus's own operations.

Operational footprint, labour and social practices, and governance quality across the company's own operations and supply chain.

Centrus publishes no standalone ESG or sustainability report; its 10-K highlights workforce investment and community presence at Piketon but discloses no Scope 1/2/3 emissions data, no diversity metrics, and governance was recently tightened via bylaw amendments that centralize dispute resolution and shareholder nomination control.

Quality of disclosure, independent third-party verification, and how much hard data backs the company's claims.

Centrus files detailed SEC financial disclosures (10-K, 10-Q, 8-K) and its NRC licensing history is publicly documented, but there is no third-party verified ESG reporting, no GHG inventory, no CDP disclosure, and no independent sustainability audit — climate-related claims rest entirely on self-description in investor materials.

Controversies, litigation, pollution, fossil-fuel lobbying, conflict-zone involvement and governance scandals. Higher means cleaner.

Centrus (as successor to USEC) is a named defendant in multiple class-action suits alleging off-site contamination from the Portsmouth GDP site, has faced a stockholder breach-of-fiduciary-duty claim over a 'poison pill' rights plan, and settled a $24M breach-of-contract dispute with DOE in 2018 — none of these are catastrophic but they represent a meaningful and recurring pattern of legal exposure.